國立高雄大學圖資館 |

Language: English

Back

Chronic lymphocytic leukemia

Catovsky, Daniel.

Chronic lymphocytic leukemia

Record Type:	Electronic resources : Monograph/item
Title/Author:	Chronic lymphocytic leukemiaedited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky.
other author:	Hallek, Michael.
Published:	Cham :Springer International Publishing :2019.
Description:	vi, 179 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Chronic lymphocytic leukemia.
Online resource:	https://doi.org/10.1007/978-3-030-11392-6
ISBN:	9783030113926$q(electronic bk.)
ISSN:	nam a2200337 a 4500

Chronic lymphocytic leukemia
Chronic lymphocytic leukemia[electronic resource] /edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky. - Cham :Springer International Publishing :2019. - vi, 179 p. :ill., digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..

Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.

This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.

ISBN: 9783030113926$q(electronic bk.)

ISSN: nam a2200337 a 4500

Standard No.: 10.1007/978-3-030-11392-6doiSubjects--Topical Terms:

520390
Chronic lymphocytic leukemia.

LC Class. No.: RC643 / .C47 2019

Dewey Class. No.: 616.99419

Chronic lymphocytic leukemia
LDR:02323nmm a2200349 a 4500 001 556904
003 DE-He213
005 20190424194549.0
006 m d
007 cr nn 008maaau
008 191127s2019 gw s 0 eng d
020 $a 9783030113926$q(electronic bk.)
020 $a 9783030113919$q(paper)
022 8 7 $a nam a2200337 a 4500
024 7 $a 10.1007/978-3-030-11392-6 $2 doi
035 $a 978-3-030-11392-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC643 $b .C47 2019
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.99419 $2 23
090 $a RC643 $b .C557 2019
245 0 0 $a Chronic lymphocytic leukemia $h [electronic resource] / $c edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a vi, 179 p. : $b ill., digital ; $c 24 cm.
490 1 $a Hematologic malignancies, $x 2197-9766
505 0 $a Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.
520 $a This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.
650 0 $a Chronic lymphocytic leukemia. $3 520390
650 1 4 $a Hematology. $3 274899
650 2 4 $a Oncology. $3 195181
700 1 $a Hallek, Michael. $3 839272
700 1 $a Eichhorst, Barbara. $3 839273
700 1 $a Catovsky, Daniel. $3 839274
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Hematologic malignancies. $3 560151
856 4 0 $u https://doi.org/10.1007/978-3-030-11392-6
950 $a Medicine (Springer-11650)